Common medication gets first major test in dialysis patients
NCT ID NCT03977207
Summary
This study is testing whether a thyroid medication called levothyroxine improves quality of life and heart health in people receiving dialysis. Researchers will enroll 336 dialysis patients who have borderline thyroid levels and randomly assign them to receive either the medication or a placebo for six months. The main goals are to see if the medication helps patients feel better physically and slows the progression of heart artery calcification.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.